Logo image of MED

MEDIFAST INC (MED) Stock Price, Forecast & Analysis

USA - NYSE:MED - US58470H1014 - Common Stock

11.65 USD
-0.14 (-1.19%)
Last: 11/11/2025, 8:25:48 PM
11.65 USD
0 (0%)
After Hours: 11/11/2025, 8:25:48 PM

MED Key Statistics, Chart & Performance

Key Statistics
Market Cap128.03M
Revenue(TTM)429.69M
Net Income(TTM)248.00K
Shares10.99M
Float10.63M
52 Week High21.98
52 Week Low11.25
Yearly Dividend0.07
Dividend Yield9.97%
EPS(TTM)-0.01
PEN/A
Fwd PEN/A
Earnings (Next)02-16 2026-02-16/amc
IPO1993-12-30
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products


MED short term performance overview.The bars show the price performance of MED in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

MED long term performance overview.The bars show the price performance of MED in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of MED is 11.65 USD. In the past month the price decreased by -12.21%. In the past year, price decreased by -35.78%.

MEDIFAST INC / MED Daily stock chart

MED Latest News, Press Relases and Analysis

MED Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EL ESTEE LAUDER COMPANIES-CL A 54.07 32.74B
KVUE KENVUE INC 15.63 32.09B
ELF ELF BEAUTY INC 25.23 4.42B
BRBR BELLRING BRANDS INC 12.76 3.49B
COTY COTY INC-CL A 18.79 3.12B
IPAR INTERPARFUMS INC 16.73 2.82B
EPC EDGEWELL PERSONAL CARE CO 7.2 862.76M
OLPX OLAPLEX HOLDINGS INC 14.25 760.47M
NUS NU SKIN ENTERPRISES INC - A 6.93 473.71M
USNA USANA HEALTH SCIENCES INC 9.7 347.31M
NATR NATURES SUNSHINE PRODS INC 21.28 352.80M
HNST HONEST CO INC/THE 42 280.40M

About MED

Company Profile

MED logo image Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. The company is headquartered in Baltimore, Maryland and currently employs 504 full-time employees. The firm is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. The company sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

Company Info

MEDIFAST INC

100 International Drive, 18th Floor

Baltimore MARYLAND 21202 US

CEO: Daniel R. Chard

Employees: 504

MED Company Website

MED Investor Relations

Phone: 14105818042

MEDIFAST INC / MED FAQ

What does MEDIFAST INC do?

Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. The company is headquartered in Baltimore, Maryland and currently employs 504 full-time employees. The firm is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. The company sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.


What is the current price of MED stock?

The current stock price of MED is 11.65 USD. The price decreased by -1.19% in the last trading session.


Does MED stock pay dividends?

MEDIFAST INC (MED) has a dividend yield of 9.97%. The yearly dividend amount is currently 0.07.


What is the ChartMill technical and fundamental rating of MED stock?

MED has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Which stock exchange lists MED stock?

MED stock is listed on the New York Stock Exchange, Inc. exchange.


When is the next dividend date for MEDIFAST INC (MED)?

The next ex-dividend date for MEDIFAST INC (MED) is September 18, 2023.


What is MEDIFAST INC worth?

MEDIFAST INC (MED) has a market capitalization of 128.03M USD. This makes MED a Micro Cap stock.


MED Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MED Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to MED. While MED has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MED Financial Highlights

Over the last trailing twelve months MED reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -100.6% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.06%
ROA 0.09%
ROE 0.12%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-160%
Sales Q2Q%-36.21%
EPS 1Y (TTM)-100.6%
Revenue 1Y (TTM)-36.29%

MED Forecast & Estimates

9 analysts have analysed MED and the average price target is 15.3 USD. This implies a price increase of 31.33% is expected in the next year compared to the current price of 11.65.

For the next year, analysts expect an EPS growth of -146.27% and a revenue growth -36.56% for MED


Analysts
Analysts46.67
Price Target15.3 (31.33%)
EPS Next Y-146.27%
Revenue Next Year-36.56%

MED Ownership

Ownership
Inst Owners79.62%
Ins Owners3.3%
Short Float %19.62%
Short Ratio13.51